Michelle N. Bradley

4.8k total citations · 3 hit papers
18 papers, 3.3k citations indexed

About

Michelle N. Bradley is a scholar working on Surgery, Molecular Biology and Immunology. According to data from OpenAlex, Michelle N. Bradley has authored 18 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 10 papers in Molecular Biology and 8 papers in Immunology. Recurrent topics in Michelle N. Bradley's work include Cholesterol and Lipid Metabolism (12 papers), Drug Transport and Resistance Mechanisms (6 papers) and Peroxisome Proliferator-Activated Receptors (5 papers). Michelle N. Bradley is often cited by papers focused on Cholesterol and Lipid Metabolism (12 papers), Drug Transport and Resistance Mechanisms (6 papers) and Peroxisome Proliferator-Activated Receptors (5 papers). Michelle N. Bradley collaborates with scholars based in United States, Spain and France. Michelle N. Bradley's co-authors include Peter Tontonoz, Antonio Castrillo, Peter A. Edwards, Sean B. Joseph, Steven J. Bensinger, Noam Zelcer, John S. Parks, Cynthia Hong, Puiying A. Mak and Stephen T. Smale and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Michelle N. Bradley

18 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension

2017 662 citations Henry G. Bone, Rachel B. Wagman et al. The Lancet Diabetes & Endocrinology profile →
LXR Signaling Couples Sterol Metabolism to Proliferation in the Acquired Immune Response

2008 555 citations Steven J. Bensinger, Michelle N. Bradley et al. Cell profile →
Apoptotic Cells Promote Their Own Clearance and Immune Tolerance through Activation of the Nuclear Receptor LXR

2009 544 citations Noelia A-González, Steven J. Bensinger et al. Immunity profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michelle N. Bradley United States	16	1.4k	1.4k	1.2k	1.0k	492	18	3.3k
Kyung‐Hyun Park‐Min United States	28	1.3k 0.9×	1.3k 1.0×	197 0.2×	708 0.7×	211 0.4×	49	2.8k
Weili Xu Singapore	10	661 0.5×	1.8k 1.3×	206 0.2×	1.2k 1.2×	585 1.2×	24	2.9k
Joseph J. Goellner United States	16	745 0.5×	1.1k 0.8×	188 0.2×	494 0.5×	259 0.5×	23	2.3k
Kyoung‐Woon Kim South Korea	30	1.2k 0.8×	830 0.6×	189 0.2×	587 0.6×	88 0.2×	64	2.7k
Marietta Armaka Greece	26	1.1k 0.7×	1.2k 0.9×	190 0.2×	495 0.5×	96 0.2×	36	2.8k
Hiroaki Matsuno Japan	31	593 0.4×	636 0.5×	415 0.3×	310 0.3×	105 0.2×	100	2.4k
Constance Zlot United States	18	684 0.5×	1.0k 0.8×	573 0.5×	431 0.4×	24 0.0×	18	2.6k
Prakash Ramachandran United Kingdom	22	1.1k 0.7×	1.1k 0.8×	880 0.7×	317 0.3×	32 0.1×	41	4.3k
John G. Emery United States	16	702 0.5×	1.4k 1.0×	94 0.1×	611 0.6×	158 0.3×	20	2.0k

Countries citing papers authored by Michelle N. Bradley

Since Specialization

Citations

This map shows the geographic impact of Michelle N. Bradley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle N. Bradley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle N. Bradley more than expected).

Fields of papers citing papers by Michelle N. Bradley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle N. Bradley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle N. Bradley. The network helps show where Michelle N. Bradley may publish in the future.

Co-authorship network of co-authors of Michelle N. Bradley

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle N. Bradley. A scholar is included among the top collaborators of Michelle N. Bradley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle N. Bradley. Michelle N. Bradley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Bone, Henry G., Rachel B. Wagman, Maria Luisa Brandi, et al.. (2017). 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension. The Lancet Diabetes & Endocrinology. 5(7). 513–523. 662 indexed citations breakdown →

Hong, Cynthia, Robert Walczak, Helena Dhamko, et al.. (2010). Constitutive activation of LXR in macrophages regulates metabolic and inflammatory gene expression: identification of ARL7 as a direct target. Journal of Lipid Research. 52(3). 531–539. 59 indexed citations

Feig, Jonathan E., Inès Pineda‐Torra, Marie Sanson, et al.. (2010). LXR promotes the maximal egress of monocyte-derived cells from mouse aortic plaques during atherosclerosis regression. Journal of Clinical Investigation. 120(12). 4415–4424. 146 indexed citations

Hsu, Jeffrey J., Jinxiu Lu, Michael Huang, et al.. (2009). T0901317, an LXR agonist, augments PKA‐induced vascular cell calcification. FEBS Letters. 583(8). 1344–1348. 16 indexed citations

A-González, Noelia, Steven J. Bensinger, Cynthia Hong, et al.. (2009). Apoptotic Cells Promote Their Own Clearance and Immune Tolerance through Activation of the Nuclear Receptor LXR. Immunity. 31(2). 245–258. 544 indexed citations breakdown →

Bensinger, Steven J., Michelle N. Bradley, Sean B. Joseph, et al.. (2008). LXR Signaling Couples Sterol Metabolism to Proliferation in the Acquired Immune Response. Cell. 134(1). 97–111. 555 indexed citations breakdown →

Naiki, Yoshikazu, Rosalinda Sorrentino, Michelle Wong, et al.. (2008). TLR/MyD88 and Liver X Receptor α Signaling Pathways Reciprocally Control Chlamydia pneumoniae-Induced Acceleration of Atherosclerosis. The Journal of Immunology. 181(10). 7176–7185. 83 indexed citations

Marathe, Chaitra, Michelle N. Bradley, Cynthia Hong, et al.. (2008). Preserved glucose tolerance in high-fat-fed C57BL/6 mice transplanted with PPARγ−/−, PPARδ−/−, PPARγδ−/−, or LXRαβ−/− bone marrow. Journal of Lipid Research. 50(2). 214–224. 46 indexed citations

Molteni, Valentina, Xiaolin Li, Fang Liang, et al.. (2007). N-Acylthiadiazolines, a New Class of Liver X Receptor Agonists with Selectivity for LXRβ. Journal of Medicinal Chemistry. 50(17). 4255–4259. 44 indexed citations

10.

Marathe, Chaitra, Michelle N. Bradley, Cynthia Hong, et al.. (2006). The Arginase II Gene Is an Anti-inflammatory Target of Liver X Receptor in Macrophages. Journal of Biological Chemistry. 281(43). 32197–32206. 82 indexed citations

11.

Ronni, Tapani, Kimberly J. Payne, Sam Ho, et al.. (2006). Human Ikaros Function in Activated T Cells Is Regulated by Coordinated Expression of Its Largest Isoforms. Journal of Biological Chemistry. 282(4). 2538–2547. 38 indexed citations

12.

Chen, Mingyi, Michelle N. Bradley, Simon W. Beaven, & Peter Tontonoz. (2006). Phosphorylation of the liver X receptors. FEBS Letters. 580(20). 4835–4841. 49 indexed citations

13.

Bradley, Michelle N. & Peter Tontonoz. (2005). LXR: A nuclear receptor target for cardiovascular disease?. Drug Discovery Today Therapeutic Strategies. 2(2). 97–103. 6 indexed citations

14.

Arai, Satoko, John M. Shelton, Mingyi Chen, et al.. (2005). A role for the apoptosis inhibitory factor AIM/Spα/Api6 in atherosclerosis development. Cell Metabolism. 1(3). 201–213. 242 indexed citations

15.

Bradley, Michelle N. & Peter Tontonoz. (2005). Lesion Macrophages Are a Key Target for the Antiatherogenic Effects of LXR Agonists. Arteriosclerosis Thrombosis and Vascular Biology. 25(1). 10–11. 12 indexed citations

16.

Joseph, Sean B., Michelle N. Bradley, Antonio Castrillo, et al.. (2004). LXR-Dependent Gene Expression Is Important for Macrophage Survival and the Innate Immune Response. Cell. 119(2). 299–309. 473 indexed citations

17.

Bradley, Michelle N., Liang Zhou, & Stephen T. Smale. (2003). C/EBPβ Regulation in Lipopolysaccharide-Stimulated Macrophages. Molecular and Cellular Biology. 23(14). 4841–4858. 104 indexed citations

18.

Weinmann, Amy S., Deborah M. Mitchell, Shomyseh Sanjabi, et al.. (2001). Nucleosome remodeling at the IL-12 p40 promoter is a TLR-dependent, Rel-independent event. Nature Immunology. 2(1). 51–57. 136 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact